Trial Profile
Study comparing the diagnostic value of Ga-68-PSMA-PET with conventional imaging in selecting patients suitable for Ra-223-chloride therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2017
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Apr 2017 New trial record
- 14 Feb 2017 Results published in the Nuklearmedizin